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Abstract
Background:  Several studies have investigated single nucleotide polymorphisms (SNPs) in
candidate genes associated with sepsis and septic shock with conflicting results. Only few studies
have combined the analysis of multiple SNPs in the same population.
Methods: Clinical data and DNA from consecutive adult patients with culture proven Gram
negative bacteremia admitted to a Danish hospital between 2000 and 2002. Analysis for commonly
described SNPs of tumor necrosis-α, (TNF-α), interleukin-1β (IL-1β), plasminogen activator-1
(PAI-1), urokinase plasminogen activator (uPA), CD14 and toll-like receptor 4 (TLR4) was done.
Results: Of 319 adults, 74% had sepsis, 19% had severe sepsis and 7% were in septic shock. No
correlation between severity or outcome of sepsis was observed for the analyzed SNPs of TNF-α,
IL-1β, PAI-1, uPA, CD14 or TLR-4. In multivariate Cox proportional hazard regression analysis,
increasing age, polymicrobial infection and haemoglobin levels were associated with in-hospital
mortality.
Conclusion: We did not find any association between TNF-α, IL-1β, PAI-1, uPA, CD14 and TLR4
polymorphisms and outcome of Gram negative sepsis. Other host factors appear to be more
important than the genotypes studied here in determining the severity and outcome of Gram
negative sepsis.
Background
The syndromes of severe sepsis and septic shock are fre-
quent and associated with high mortality [1]. Their patho-
physiology is complex and results from the interaction
between infecting pathogens and inflammatory and coag-
ulation pathways [2,3]. Among the numerous microor-
ganisms that cause sepsis, Gram negative bacteria,
predominantly Enterobacteriacea, account for one third of
all cases [1].
Innate host defence is integrally linked to inflammation
and coagulation [3,4]. Gram negative bacterial lipopoly-
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saccharide (LPS, endotoxin) is sensed by LPS-binding pro-
tein (LBP) by the human host. The LPS-LBP complex
binds to the cellular surface receptor CD14 and interacts
with the toll-like receptor 4 (TLR4) to induce nuclear fac-
tor κ-B signalling and transcription of cytokines, chemok-
ines, adhesion and coagulation factors [5]. Among these,
tumor necrosis factor α (TNF-α) and interleukin-1β (Il-
1β) are decisive proinflammatory mediators. Blood clot-
ting can be initiated by TNF-α and endotoxin and is coun-
teracted by fibrinolysis. Fibrinolysis is initiated by two
types of plasminogen activators, the urokinase-type (uPA)
and the tissue-type (tPA) and may be inhibited by the
plasminogen activator inhibitors, PAI-1 and PAI-2.
Genetic epidemiologic studies suggest a strong genetic
influence on the outcome from sepsis [6]. Since dysregu-
lation of innate immunity is believed to be central for the
manifestations of sepsis, studies of genetic susceptibility
to and outcome of septic shock have focused on genes
involved in inflammatory and coagulation pathways. Syn-
onymous and non-synonymous single nucleotide poly-
morphisms (SNPs) may alter the expression or function of
transcribed gene products. We included SNPs that had
been shown in other studies to have either clinical or
experimental relevance with sepsis outcome through the
inflammatory and coagulation pathways. Data indicate
that SNPs of TNF-α [7,8], Il-1β [9,10], PAI-1 [11,12], and
CD14 [13] may be associated with a poor prognosis from
sepsis. Polymorphisms in TLR4 [14] and CD14 [13] are
further associated with an increased susceptibility to infec-
tion. The uPA polymorphism has not previously been
studied in sepsis.
Here we present a genetic association study of Gram neg-
ative sepsis with focus on six SNPs previously linked to
sepsis pathogenesis and survival.
Methods
Patients
All patients older than 17 years admitted to Hvidovre
Hospital between June 2000 and May 2002 with a posi-
tive blood culture yielding a Gram negative organism
were included in the study. Demographic, clinical and
laboratory data were extracted on a standardized form.
Sepsis, severe sepsis and septic shock were classified
according to international guidelines [2]. The study was
approved by the Ethics Committee for Copenhagen and
Frederiksberg Counties (01-085/2000). None of the
patients were lost to follow-up.
Deoxyribonucleic Acid Extraction
1.5 mL of positive blood culture media was lysed with 1.5
mL of 5 M guanidinium-HCl-100 mM Tris (pH 8.0) [15].
DNA was then extracted with QIAamp mini Spin columns
(Qiagen, Hilden, Germany) as described by the manufac-
turer and stored at -20°C.
Genotyping
Primers, probes and restriction enzymes are shown in
Table 1. The TNF-α SNP was analyzed using a Light Cycler
(Roche, Basel, Switzerland) as previously described [16].
Il-1β SNP was analyzed by Polymerase Chain Reaction
Restriction Fragment Length Polymorphism (PCR-RFLP)
analysis and PAI-1 by allele specific PCR as described [17].
uPA, TLR4, and CD14 were analyzed using a microsphere
based assay (Luminex 100, Luminex Corp., Austin, TX).
Wild type and mutant allele capture oligonucleotide
probes (Table 1) were synthesized and modified at the 5'
terminus (TAG Copenhagen, Denmark) and coupled to
carboxylated microspheres as described by Luminex. PCR
was performed using a multiplex PCR (Qiagen multiplex
PCR kit, Qiagen) with biotin-labelled primers (Table 1),
and conditions included 95°C for 15 min, 40 cycles of
92°C for 30 seconds, 55°C for 30 seconds and 72°C for
60 seconds. Each biotinylated amplicon was denatured at
95°C for 5 min and hybridized at 54°C for 7.5 min. Sam-
ples were filtered through a 1.2 µm Durapore filter,
washed, resuspended with streptavidin-R-phycoerythrin,
incubated for 10 min and then filtered and washed again
before being read with a Luminex-100 according to man-
ufacturer's protocol. All genotyping was performed
blinded to study details. The TNF-α, uPA, TLR4, and
CD14 SNP results obtained by Lighcycler and Luminex
analysis were verified by PCR-RFLP with a minimum of 40
randomly selected samples for each SNP [18-21]. Congru-
ence was found for all samples. IL-1β and PAI-1 SNPs
were not assessed by other means.
Hardy-Weinberg equilibrium (HWE)
HWE analysis was performed for each SNP by comparing
the detected genotype distribution with the theoretical
distribution estimated on the basis of the SNP allelic fre-
quencies. P > 0.05 (χ2 statistics) was considered to indi-
cate equilibrium.
Statistics
Genotype distributions were compared using χ2 statistics.
Relative risk (RR) with 95% confidence interval (CI) of in-
hospital mortality associated with genotypes and other
variables was estimated using Cox proportional hazards
regression analysis by forced entry. Each covariate was
entered separately and covariates that were associated
with disease at the P < 0.1 level were included in the mul-
tivariate model. Survival curves were constructed by the
method of Kaplan-Meier. The date of diagnosis (baseline)
was defined as the date of blood culture. Analysis was per-
formed with SPSS 11.5 (Statistical Package for Social Sci-
ences, Chicago, IL.). Power And Precision 2.00 (Biostat,BMC Infectious Diseases 2007, 7:108 http://www.biomedcentral.com/1471-2334/7/108
Page 3 of 7
(page number not for citation purposes)
Englewood, NJ) was used to calculate statistical power to
detect changes in survival.
Results
Patient characteristics
From June 2000 through May 2002, 452 consecutive epi-
sodes of Gram negative bacteremia were diagnosed
among 427 individuals at Hvidovre Hospital. Of these,
319 were a first episode and had DNA collected. There
were no statistical significant differences between individ-
uals included and excluded from the present study. The
median age was 76 (interquartile range: 61–84), 172
(54%) of subjects were women, and 255 (80%) had at
least one chronic underlying illness. In most patients the
infectious focus was the urinary tract (83%) and the most
common Gram negative bacteria were Escherichia coli
(69%) and Klebsiella pneumoniae (11%). Nineteen other
Gram negative bacteria accounted for the remaining 20%.
Genotypes
Of 319 included specimens, TNF-α was amplifiable in
304, Il-1β in 317, PAI-1 in 316, uPA in 313, TLR4 in 301,
and CD14 in 314. All genotypes were in Hardy-Weinberg
equilibrium. Distributions are shown in Table 2.
Genotypes and baseline characteristics
No associations were found between genotypes and
demographics (age, sex, and comorbidity), temperature,
mean arterial blood pressure, white blood cell count, C-
reactive protein or causative organism at the time of blood
culture.
Disease severity and genotype
The majority of patients met the criteria for sepsis at the
time of blood culture (74%). 19% met the criteria for
severe sepsis and 7% were in septic shock.
Neither TNF-α, Il-1β, PAI-1, uPA, TLR4, nor CD14 SNPs
were associated with disease severity.
Mortality and genotype
In total 63 (19%) died during hospitalization. Mortality
increased with severity of disease from 17% for sepsis to
25% and 38% for severe sepsis and septic shock, respec-
tively (Figure 1). We did not detect any association
between the tested SNPs and outcome (in-hospital, 1 or 3
month mortality rates) when tested for the whole group
or tested for each of the severity groups (Table 3).
Multivariate analysis of factors associated with outcome
A possible association of genotypes and other baseline
variables with in-hospital mortality was further explored
by Cox regression analysis. By univariate analysis, increas-
ing age, disease severity, polymicrobial infection, inten-
sive care admission, lower haemoglobin, leukocytosis,
elevated C-reactive protein, elevated plasma urea, and ele-
vated alanine transferase was associated with in-hospital
mortality. Sex, comorbidity, alcoholism, mean arterial
Table 1: Primers, probes and restriction enzymes
Gene SNP Sense primer Antisense primer Probe/restriction enzyme
TNF-α G- 308 A 5'-
TAGGTTTTGAGGGGCATGGGGA
C-3'
5'- TCTCGGTTTCTTCTCCATCG -
3'
5'-
TAGGTTTTGAGGGGCATGGGGA
C-3'-fluorescein
5'-LC Red640-
GGGTTCAGCCTCCAGGGTCCTA
CACAC-3'-phosphate
Il-1β C3953T 5'-CACTCCCAGCTTCATCCCTA-3' 5'-AGGTGCATCGTGCACATAAG-
3'
Taq I
PAI-1 4G/5G 5G allele; 5 ' -
GTCTGGACACGTGGGGG-3 ' 4G 
allele; 5 ' -
GTCTGGACACGTGGGGA-3 '
5 ' -
TGCAGCCAGCCACGTGATTGTC
TAG-3 '
None
uPA C 422 T 5'-biotin-
ACTGCAGGAACCCAGACAAC-3'
5'-AGGGAGGCAGGTAGGAGAAA-
3'
5'-GCCTAAAGCCGCTTGTCCAA-
3' 5'-
GGCCTAAAGCTGCTTGTCCAA-3'
TLR4 A 896G 5'-biotin-
AGTCCATCGTTTGGTTCTGG-3'
5'-
AATAGTCACACTCACCAGGGAA
A-3'
5'-
AGTCAATAATATCATCGAGGTAG
-3' 5'-
AGTCAATAATACCATCGAGGTAG
-3'
CD14 C-159T 5'-biotin-
CACCCACCAGAGAAGGCTTA-3'
5'-ATCACCTCCCCACCTCTCTT-3' 5'-GGAGGGGGGCCGTAACA-3' 5'-
GGGAGGGGGACCGTAACAG-3'
TNF-α: tumor necrosis factor alpha; Il-1β: interleukin-1 beta; PAI-1: plasminogen activator inhibitor 1; uPA: urokinase-type plasminogen activator; 
TLR4: toll-like receptor 4; CD14: cluster of differentiation 14; A: adenine; T: thymidine; C: cytosine; G: guanine; SNP: single nucleotide 
polymorphism; LC: light cyclerBMC Infectious Diseases 2007, 7:108 http://www.biomedcentral.com/1471-2334/7/108
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pressure, temperature, lymphocyte count, platelet count,
bilirubin and lactate dehydrogenase was not associated
with in-hospital mortality. Variables were then grouped in
two categories due to the many covariates associated with
mortality in univariate analysis relative to the number of
events and, thereby, the risk of overfitting the multivariate
analysis. Model 1 consisted of demographic variables and
microbiological findings and model 2 consisted of labora-
tory values. Variables associated with in-hospital mortal-
ity at P < 0.05 were then fitted in a third model. By this
approach, increasing age and polymicrobial infection was
associated with a poor outcome, whereas increasing hae-
moglobin levels were associated with a better outcome
(Table 4). Finally, based on this analysis, we stratified for
polymicrobial infection and/or entered age and/or hae-
moglobin levels in the Cox analysis in order to investigate
whether SNPs affected outcome in subgroups of patients
with Gram negative sepsis. None of the SNPs were associ-
ated with outcome.
Discussion
We did not find any association between disease severity
and putative SNPs involved in inflammatory and coagula-
tion pathways during the course of sepsis nor were any of
the SNPs associated with outcome. The homozygous TNF-
α AA and heterozygous TLR4 AG SNPs were associated
with an increased but statistically non-significant risk of
death.
Genetic association studies notoriously contradict one
another [22]. Conflicting results have been reported for
TNF-α (G-308A), which was associated to disease severity
and outcome in some [7,8,23] but not other studies [24-
26]. Controversy also exists regarding the role of for PAI-
1 [11,12,27], CD14 (C-159T) [13,28], TLR4 (A896G)
[20,29], although IL-1β (C3953T) have consistently been
reported to be without association to disease severity or
outcome [30]. Methological problems may explain many
of the discrepancies. In particular, many studies have
insufficient sample size to make firm statistical conclu-
sions. The present study provided > 80% power to detect
Table 2: Association between genotype and disease severity
Genotype Sepsis (%) Severe sepsis 
(%)
Septic shock (%) All (%) P value
TNF-α (G-308A)
GG 134 (60) 35 (58) 13 (65) 182 (60)
GA 80 (36) 20 (33) 6 (30) 106 (35)
AA 10 (4) 5 (9) 1 (5) 16 (5) 0.92
Il-1β (C3953T)
CC 135 (57) 32 (53) 11 (52) 178 (56)
CT 83 (35) 24 (40) 10 (48) 117 (37)
TT 18 (8) 4 (7) 0 22 (7) 0.5
PAI-1 (4G/5G)
4G-4G 67 (28) 16 (27) 7 (33) 90 (28)
4G-5G 134 (58) 37 (62) 12 (57) 183 (58)
5G-5G 35 (14) 7 (11) 2 (10) 44 (14) 0.89
uPA (C422T)
CC 135 (58) 41 (67) 11 (52) 187 (60)
CT 87 (38) 19 (31) 8 (38) 114 (36)
TT 9 (4) 1 (2) 2 (10) 12 (4) 0.30
TLR4 (A 896G)
AA 204 (91) 52 (91) 18 (86) 274 (91)
AG 19 (9) 5 (9) 3 (14) 27 (9)
G G 00 00 0 . 5 2
CD14 (C-159T)
CC 72 (31) 13 (22) 7 (33) 92 (29)
CT 117 (50) 30 (51) 9 (43) 156 (50)
TT 45 (19) 16 (27) 5 (24) 66 (21) 0.57
TNF-α: tumor necrosis factor alpha; Il-1β: interleukin-1 beta; PAI-1: plasminogen activator inhibitor 1; uPA: urokinase-type plasminogen activator; 
TLR4: toll-like receptor 4; CD14: cluster of differentiation 14; A: adenine; T: thymidine; C: cytosine; G: guanineBMC Infectious Diseases 2007, 7:108 http://www.biomedcentral.com/1471-2334/7/108
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a 1.5-fold increase in relative risk of death for the hetero-
zygous forms of TNF-α, Il-1β, PAI-1, uPA, and CD14,
while a 2.5-fold was necessary to provide 80% power to
detect differences associated with the lesser frequent allele
frequencies of TLR4. Although, the level of association
may be debated, we find 1.5–2.5-fold changes reasonable.
The study was, however, underpowered to detect associa-
tions with the lesser frequent homozygous TNF-α, IL-1β,
uPA and heterozygous TLR4 genotypes. Publication bias
may also influence the true genetic association between
disease severity and outcome because negative association
studies are less likely to be published than studies that
find an association. Our negative findings may be due to
the fact that our population differs from the previous
reported studies showing a positive correlation, e.g. stud-
ies of meningococcal disease alone (PAI-1, TLR4 and TNF-
α) and of patients with severe sepsis in intensive care set-
tings (TNF-α and TLR4).
Strengths of the present study include the fact that the
cohort represents unselected and consecutive patients
with Gram negative sepsis. Limitations relate to the sam-
ple size because larger samples would detect smaller asso-
ciations than studied here. Meta-analysis of multiple
cohorts could add power to discriminate between poten-
tial genetic associations and statistical uncertainties of
polymorphisms of genes in the inflammatory and coagu-
lative pathways. Use of novel technologies that permit
genome-wide genetic analysis of SNPs and haplotypes
will likely be useful in future genetic association studies.
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90-day survival from Gram negative sepsis according to dis- ease severity Figure 1
90-day survival from Gram negative sepsis according to dis-
ease severity. Log-rank test: P = 0.014.
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Table 3: In-hospital mortality according to genotype
Genotype In-hospital mortality (%) P value
TNF-α (G-
308A)
GG 34/182 (19)
GA 20/106 (19)
AA 6/16 (38) 0.19
Il-1β (C3953T)
CC 32/178 (18)
CT 25/117 (21)
TT 5/22 (23) 0.61
PAI-1 (4G/5G)
4G-4G 15/90 (17)
4G-5G 37/183 (20)
5G-5G 11/44 (25) 0.61
uPA (C422T)
CC 40/187 (21)
CT 20/114 (18)
TT 2/12 (17) 0.86
TLR4 (A 896G)
AA 49/274 (18)
AG 8/27 (30)
GG - 0.11
CD14 (C-
159T)
CC 18/92 (20)
CT 33/156 (21)
TT 11/66 (17) 0.90
TNF-α: tumor necrosis factor alpha; Il-1β: interleukin-1 beta; PAI-1: 
plasminogen activator inhibitor 1; uPA: urokinase-type plasminogen 
activator; TLR4: toll-like receptor 4; CD14: cluster of differentiation 
14; A: adenine; T: thymidine; C: cytosine; G: guanineBMC Infectious Diseases 2007, 7:108 http://www.biomedcentral.com/1471-2334/7/108
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